(Reuters) — HCA Holdings (NYSE:HCA), the largest for-profit U.S. hospital operator, said a procedure for removing uterine fibroids that’s been linked to the spread of cancer will no longer be performed at its facilities.
Wall Street Beat
Medtronic expects to free up to $4B after IRS beef is settled
Will Stryker bid on Smith & Nephew this week?
Second Sight CEO Greenberg: Next-gen ‘bionic eye’ could treat nearly all forms of blindness
Shares soar for InVivo after spinal cord study update | Medtech Wall Street news for the week of November 17, 2014
Cardica plunges after pulling MicroCutter Xchange 30 stapler
Venture capital investment in medtech grows in Q3
Venture capitalists put more cash into more deals for medical device companies during the 3rd quarter, according to a report from PricewaterhouseCoopers.
Medical device companies pulled down $586 million in 78 deals during the 3rd quarter, up 13% in dollars and 18% in deal volume compared with Q3 2013.